Jiangsu Vanguard Pharmaceutical successfully promoted to gold medal enterprise
Published Time:
2016-06-15
In 2013, Jiangsu Vanguard Pharmaceutical Co., Ltd. continuously increased its production capacity, expanded new markets, and increased investment. By December 30, it achieved sales revenue of nearly 200 million yuan and paid over 20 million yuan in taxes, successfully upgrading from a silver enterprise to a gold enterprise.
With the expansion of the company's production scale and the requirement to make the enterprise bigger and stronger before and after listing, the existing production status and warehousing conditions can no longer meet the development needs. The company submitted an application to the Municipal Development and Reform Commission for the expansion of workshops and warehouses. This project covers an area of 13,300 square meters and has a total investment of approximately 40 million yuan. It is expected to be completed and accepted in February 2014. At that time, the new water injection products will be put into production, which will greatly increase sales revenue.
For many years, the company has always paid great attention to technological research and development of independent innovation technologies. In its early stages, it established a professional R&D team with solid foundation and rich experience. There are currently 37 professional R&D personnel, accounting for 17.6% of the company's total employees. They are very familiar with the company's product technology development, are young and energetic, are full of innovative spirit, and have strong product R&D capabilities. More than 30 new drugs currently under development are awaiting approval from the State Food and Drug Administration.
Recommended News
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.